Back to Trades
Riley Jeffrey Scott
DirectorCIK 0001487645
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Riley Jeffrey Scott, Director, has filed 1 SEC report (2026), all concentrated in Gain Therapeutics, Inc. (GANX), totaling $42.0K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Jul 17 | GANX Gain Therapeutics, Inc. | Riley Jeffrey Scott | Director | Award | $42.0K |
1 filing